# Current Feature Audit (As Implemented)

## Frontend

### Public and Marketing
- Landing page with hero, trust strip, category chips, featured/new products, promo strip, blog cards, and footer.
- Responsive header with mobile menu and category scroller.
- Improved logo visibility in header/footer.
- Section anchor navigation wired between header/footer and landing sections.

### Authentication UX
- Login page with role switch (Admin/Customer).
- Register page for new Admin/Customer account creation.
- Session-aware redirects from auth pages if already logged in.
- Logout integrated in user menu.

### Admin Module (/dashboard)
- Dashboard KPIs and charts.
- Inventory, suppliers, purchase orders, sales/POS, prescriptions, reports, users, settings pages.
- Sidebar and header navigation with responsive behavior.

### Customer Module (/customer)
- Customer overview dashboard.
- My Orders page.
- My Prescriptions page.
- Profile page.

## Backend and Auth

### Route Handlers
- POST /api/auth/login
- POST /api/auth/register
- POST /api/auth/logout
- GET /api/auth/me

### Session Security Model
- Signed token session stored in HttpOnly cookie (pharmanest_session).
- Session includes role and expiry.
- Middleware route protection for role-segregated modules.

### Access Control
- /dashboard requires admin role.
- /customer requires customer role.
- /login and /register auto-redirect authenticated users to role home.

## Technical Constraints Currently Present
- User registration currently uses in-memory storage (resets on server restart).
- No persistent database yet.
- Build config currently ignores TypeScript and ESLint errors in next.config.ts.
- Lint command still requires one-time ESLint migration setup.

## Immediate Priority Recommendations
1. Add database persistence for users, products, orders, and prescriptions.
2. Replace SHA256 password hashing with bcrypt/argon2 plus salts.
3. Enforce strict build checks by enabling TypeScript and ESLint in CI.
4. Add customer cart and checkout flow as next product milestone.
